100 Independence,610 Market Street
Philadelphia , PA, 19106-2354

Rank

Rank Universe
0 355

Summary

The fund looks to grow capital by avoiding market losses.

The investment process focuses on large cap companies that are trading below their intrinsic value. The fundamental research process looks for financially strong companies with stable earnings and cash flow and a management with a track record of rewarding shareholders.

The research process also takes into account macro-economic views, interest rate trends, industry More

Link

Directors

Dec 11, 2023
  • Thomas K. Whitford
  • Shawn K. Lytle
  • Frances A. Sevilla-Sacasa
  • Joseph W. Chow
  • Janet L. Yeomans
  • Christianna Wood
  • John A. Fry
  • Ann D. Borowiec
  • Sandra A.J. Lawrence
  • Joseph Harroz, Jr.
  • H. Jeffrey Dobbs
  • Jerome D. Abernathy

Chief Compliance Officer

  • William Speacht

Fund Manager(s)

  • Scot Thompson
  • Benjamin Leung

Price

  • $ 6.36 ( +0 )
    Mar 14, 2023
    Last Close
  • Net Assets
  • $274.4M
    Feb 27, 2023
  • Holding
  • 63
    Feb 27, 2023
    More

  • 52-Week High/Low
  • $7.5 - $6.15
  • Turnover
  • 57%
  • Expense Ratio
  • 0.77%

Company Name

Holding

Exxon Mobil Corp 6.16 %
Merck & Co Inc 4.45 %
Bristol-Myers Squibb Co 3.95 %
Gilead Sciences Inc 3.83 %
TJX Cos Inc/The 3.61 %
Cisco Systems Inc 3.6 %
Cigna Corp 3.57 %
Johnson & Johnson 3.46 %
ConocoPhillips 3.39 %
Philip Morris International In 3.32 %
More 3.32 %

Documents

Prospectus

Annual Reports

Fact Sheet

Q2 2022 Q2 2021

Performance

YTD

-

3 Year

-6.19%

5 Year

-31.8%

Best

15.54%

2017

Worst

-14.22%

2019

Alpha

FIUUX S&P 500

Chart +